A Study of Amivantamab in Participants with Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (PALOMA-2). Here, EGFR is linked to non-small cell lung carcinoma.